Kings Path Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$1.75M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$1M |
| 3 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$948K |
| 4 |
Avantis US Large Cap Value ETF
AVLV
|
+$947K |
| 5 |
Dimensional Global Core Plus Fixed Income ETF
DFGP
|
+$817K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$695K |
| 2 |
ARIS
Aris Water Solutions
ARIS
|
+$502K |
| 3 |
ANI Pharmaceuticals
ANIP
|
+$395K |
| 4 |
iRadimed
IRMD
|
+$368K |
| 5 |
i3 Verticals
IIIV
|
+$291K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.07% |
| 2 | Financials | 2.01% |
| 3 | Consumer Discretionary | 1.85% |
| 4 | Technology | 1.69% |
| 5 | Energy | 1.67% |
Similar funds
Kings Path Partners's Q3 2025 Portfolio in Review
As of Q3 2025, Kings Path Partners held 342 positions worth $271M, up 9.3% from $248M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Kings Path Partners deployed $9.84M of net new capital in Q3 2025, opening 59 new positions and adding to 56 existing holdings. Its largest new stake was BNY Mellon Core Bond ETF: 9,873 shares worth $421K.
By sector, the portfolio is most concentrated in Healthcare at 2.1% of assets, down from 2.7% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Aris Water Solutions, an estimated $502K trimmed.
- Kings Path Partners's largest Q3 2025 buy was BNY Mellon Core Bond ETF: 9,873 shares worth $421K.
- Kings Path Partners added most to Vanguard Total Stock Market ETF in Q3 2025, an estimated $1.75M increase.
- Kings Path Partners's biggest Q3 2025 reduction was Aris Water Solutions, cutting an estimated $502K.
- Kings Path Partners fully exited Eli Lilly in Q3 2025, selling an estimated $695K.
- Kings Path Partners's ten largest holdings make up 58% of its $271M portfolio in Q3 2025.
- Kings Path Partners opened 59 new positions and closed 24 in Q3 2025.
- Kings Path Partners's portfolio value rose 9.3% quarter-over-quarter to $271M.
Based on Kings Path Partners's 13F filing for Q3 2025, filed 13 Jul 2026.